I agree that this site is using cookies. You can find further informations here.
X
Dougherty, Mikaela
10  results:
Search for persons X
?
1

Energy expenditure in myelofibrosis patients treated with a..:

Tremblay, Douglas ; Dougherty, Mikaela ; Mascarenhas, John.
Frontiers in Endocrinology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
2

A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients w..:

Mascarenhas, John ; Migliaccio, Anna Rita ; Kosiorek, Heidi...
Clinical Cancer Research.  29 (2023)  18 - p. 3622-3632 , 2023
Link: https://doi.org/10.1158/..
 
?
3

PD-1 inhibition in advanced myeloproliferative neoplasms:

Hobbs, Gabriela ; Cimen Bozkus, Cansu ; Moshier, Erin...
Blood Advances.  5 (2021)  23 - p. 5086-5097 , 2021
Link: https://doi.org/10.1182/..
 
?
4

Safety and Efficacy: Clinical Experience of Venetoclax in C..:

Feld, Jonathan ; Tremblay, Douglas ; Dougherty, Mikaela...
HemaSphere.  5 (2021)  4 - p. e549 , 2021
Link: https://doi.org/10.1097/..
 
?
5

Venetoclax and hypomethylating agent combination therapy in..:

Tremblay, Douglas ; Feld, Jonathan ; Dougherty, Mikaela...
Leukemia Research.  98 (2020)  - p. 106456 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Energy expenditure in myelofibrosis patients treated with a..:

Tremblay, Douglas ; Dougherty, Mikaela ; Mascarenhas, John.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339379/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
7

PD-1 inhibition in advanced myeloproliferative neoplasms:

Hobbs, Gabriela ; Cimen Bozkus, Cansu ; Moshier, Erin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152999/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
8

Energy expenditure in myelofibrosis patients treated with a..:

Douglas Tremblay ; Mikaela Dougherty ; John Mascarenhas.
https://www.frontiersin.org/articles/10.3389/fendo.2023.1141029/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
9

Image_1_Energy expenditure in myelofibrosis patients treate..:

Douglas Tremblay ; Mikaela Dougherty ; John Mascarenhas.
doi:10.3389/fendo.2023.1141029.s001.  , 2023
Link: https://doi.org/10.3389/..
 
?
10

Safety and Efficacy: Clinical Experience of Venetoclax in C..:

Jonathan Feld ; Douglas Tremblay ; Mikaela Dougherty...
http://journals.lww.com/10.1097/HS9.0000000000000549.  , 2021
Link: https://doi.org/10.1097/..
 
1-10